INSIGHTS ON CLINICAL TRIAL DESIGN
-
Hey There. We're Scout
Learn how clear workflows, proactive support, and accessible technology help translate services into real participant retention.
-
Integrating Clinical Operations And Pharmacovigilance for Safer Trials
Learn how integrated planning strengthens decision-making, reduces downstream risk, and supports patient safety while protecting timelines in high-risk studies.
-
Sustaining Participation In A 20-Year Alzheimer's Family Study
Learn how home-based visits can reduce burden, improve retention, and support long-term follow-up in complex clinical studies requiring years of continuous participation.
-
Solutions To The Challenges Of Oncology Trials
This significant Phase III trial, one of the largest global studies in head and neck cancer, faced considerable challenges including enrollment delays and an intricate study design.
-
Navigating Project Optimus And The Rapidly Changing Oncology Development Landscape9/1/2025
Project Optimus and adaptive trial designs are reshaping oncology development, improving patient outcomes, and streamlining approval pathways.
-
Decentralized Trials: The Value Of Direct-To-Patient, Pharmacy-Led Solutions5/8/2026
Pharmacy-led DTP models cut site burden, improve inventory control, and expand trial access. Learn how to optimize your decentralized trial supply chain for compliance and patient outcomes.
-
From Weeks To Days: An Innovative Approach To Patient Recruitment10/28/2025
Discover how AI-driven, personalized communication can break linguistic and literacy barriers to make patient recruitment faster, more inclusive, and 30% more effective.
-
From Protocol Design To Actual Patients In Studies4/22/2026
Explore how clinical trial success increasingly depends on aligning recruitment strategies with protocol complexity through data-driven insights and tailored engagement approaches.
-
Streamlining The Clinical Trial Workflow From Protocol Design To Regulatory Submission1/27/2026
Learn how to create a direct line from clinical planning and protocol design to clinical trial disclosure to optimize efficiency across the entire trial lifecycle.
CLINICAL TRIAL DESIGN SOLUTIONS
-
With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
-
Veristat has built a team of scientific-minded experts who have supported more than 300 projects for endocrine/metabolic disorder treatments and prepared over 30 marketing applications, 60% of which have been approved or authorized to date.
-
Metabolic and endocrine diseases are a rising therapy area focus for clinical research due to the high demand for novel therapies that are challenged with proving safety and efficacy.
-
Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.
-
Veristat ensures that your clinical trial or program design supports your regulatory strategy, whether you plan to run a single pivotal trial or multiple trials.